Burzynski Research Institute, Inc. (BZYR)

OTCMKTS · Delayed Price · Currency is USD
0.0370
+0.0060 (19.35%)
Jun 12, 2025, 10:48 AM EDT
-13.95%
Market Cap 4.86M
Revenue (ttm) n/a
Net Income (ttm) -1.39M
Shares Out 131.45M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,400
Average Volume 2,264
Open 0.0433
Previous Close 0.0310
Day's Range 0.0370 - 0.0433
52-Week Range 0.0301 - 0.0770
Beta 1.84
RSI 52.02
Earnings Date May 27, 2025

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1977
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol BZYR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.